RHEUMAPREG 2027

Rheumapreg 2027

Abstract Submission

Abstract Submission Deadline: May 19th, 2027

ONLINE SUBMISSION SOON AVAILABLE

Topics

  • Antiphospholipid Syndrome: from understanding to evolving management
  • Artificial reproductive techniques and the role of fertility preservation in rheumatic diseases
  • Challenges of fertility in context of rheumatic disease and social changes
  • From placenta pathology to adverse obstetric outcome: mechanisms and management (Preeclampsia, FGR, Placental insufficiency)
  • Translational and basic research in rheumatic diseases and fertility and pregnancy
  • Immunosuppressive therapy of rheumatic diseases before and during pregnancy and lactation
  • Long-term follow up of children
  • Management of Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, and Juvenile Idiopathic Arthritis during Pregnancy
  • Myositis, Scleroderma, Sjögren’s and Vasculitis in pregnancy
  • Menopause in patients with rheumatic diseases
  • Male reproductive health
  • Patient perspectives: family planning with rheumatic diseases
  • Pregnancy with Lupus and other high-risk pregnancies
  • Recurrent Pregnancy loss and the role of additional therapy: myth and evidence
  • Revisiting Osteoporosis in reproductive years
  • Supporting new mothers with rheumatic diseases: post-partum challenges
  • Update on the registries
  • Other
  • Prepregnancy counseling
  • How rheumatic diseases influence sexual health

General Regulation

  • All abstracts must be submitted via the official abstract submission portal (URL available during the submission period). Please note that the Congress Organizers are not able to accept abstracts submitted via e-mail. Should you have any problems in submitting an abstract online, please contact the Organizing Secretariat at rheumapreg2027@aimgroup.eu
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
  • Abstracts must be original. The Rheumapreg Congress accepts encore abstracts presented at other conferences previously, but it is advisable when possible to include updated research or analysis data to highlight the progress of your research and keep the information in the abstract up-to-date. If some of the data in the abstract is previously published in a journal or other congress proceedings, it is the author’s responsibility to confirm with the publisher whether the submission of the abstract for Rheumapreg 2027 will breach any copyright policies of the publisher.
  • Rheumapreg 2027 does not place an embargo over the submitted abstracts and authors are free to reuse their abstracts.
  • Trials in progress are accepted.
  • Currently, it is not foreseen a late-breaking submission.
  • All abstracts must be submitted in English.
    .

A single account can be used to submit multiple abstracts, but each abstract must have a different presenting author.

Abstract Requirements

  • When you submit the abstract, please indicate your preferred method of presentation (poster or oral communication) and select one of the categories that best describes the abstract.
  • The maximum size of abstracts is limited to 350 words (approx. 3.200 characters including spaces).
  • The abstracts should state clearly:
  • Objectives
  • Methods
  • Results
  • Conclusions
  • Tables, charts or other graphics could be included as well as one image in jpeg format.
  • It is the author’s responsibility to submit a correct abstract; any errors in spelling, grammar or scientific fact will be reproduced as typed by the author, if accepted.
  • Please follow carefully the instructions reported on the online pages and fill in all the requested fields, in order to guarantee a correct and complete publication of the text.
  • Changes to the abstracts can only be accepted until the deadline and can be added in the text using the User ID and Password received when submitting.
  • The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
  • Before the abstract submission deadline, you may reopen and edit your abstract if necessary. Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after the submission deadline.
  • Please contact us if you have not received confirmation that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.

Abstract Submission

Abstracts can be submitted exclusively through the Congress website and no later than May 19th, 2027. 

Abstract Notification

Once the abstract is submitted, a confirmation email will be sent to the registered author’s e-mail address provided in the ‘Personal Details’ section.
Notification of abstract acceptance will be sent via email by June 16th, 2027.
The registered author is responsible for sharing the outcome of the abstract examination and any other related information with their co-authors.
Please note that the presenting author of the accepted abstract must be registered to attend the Congress.

Information for Presenters

Oral Presentations
The selected presenting authors are requested to upload their presentation (landscape format 16:9) on a USB drive or laptop and deliver it to the slide center room at least one hour before the beginning of the session.

Posters
All posters must have maximum dimensions of 70 x 100 cm (portrait format).
Please note that poster boards will be set up in a reserved area of the Congress venue and must remain up throughout the Congress, so that participants will be able to view them at their convenience.